These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 7481419)
1. Acute, subchronic and withdrawal sleep EEG changes during treatment with paroxetine and amitriptyline: a double-blind randomized trial in major depression. Staner L; Kerkhofs M; Detroux D; Leyman S; Linkowski P; Mendlewicz J Sleep; 1995 Jul; 18(6):470-7. PubMed ID: 7481419 [TBL] [Abstract][Full Text] [Related]
2. Antidepressive treatment with amitriptyline and paroxetine: comparable effects on heart rate variability. Lederbogen F; Gernoth C; Weber B; Colla M; Kniest A; Heuser I; Deuschle M J Clin Psychopharmacol; 2001 Apr; 21(2):238-9. PubMed ID: 11270923 [No Abstract] [Full Text] [Related]
3. Double-blind multicenter study of paroxetine and amitriptyline in depressed inpatients. Möller HJ; Berzewski H; Eckmann F; Gonzalves N; Kissling W; Knorr W; Ressler P; Rudolf GA; Steinmeyer EM; Magyar I Pharmacopsychiatry; 1993 May; 26(3):75-8. PubMed ID: 8415897 [TBL] [Abstract][Full Text] [Related]
4. A multicenter double-blind trial of paroxetine versus amitriptyline in depressed inpatients. Stuppaeck CH; Geretsegger C; Whitworth AB; Schubert H; Platz T; König P; Hinterhuber H; Fleischhacker WW J Clin Psychopharmacol; 1994 Aug; 14(4):241-6. PubMed ID: 7962679 [TBL] [Abstract][Full Text] [Related]
5. Paroxetine versus amitriptyline for treatment of depression associated with rheumatoid arthritis: a randomized, double blind, parallel group study. Bird H; Broggini M J Rheumatol; 2000 Dec; 27(12):2791-7. PubMed ID: 11128665 [TBL] [Abstract][Full Text] [Related]
6. A double-blind, multicentre study to assess the tolerability and efficacy of paroxetine compared with amitriptyline in the treatment of depressed patients in Australian general practice. Freed E; Goldney R; Lambert T; Tiller J; Johnston R Aust N Z J Psychiatry; 1999 Jun; 33(3):416-21. PubMed ID: 10442799 [TBL] [Abstract][Full Text] [Related]
7. Randomised controlled study of sleep after nefazodone or paroxetine treatment in out-patients with depression. Hicks JA; Argyropoulos SV; Rich AS; Nash JR; Bell CJ; Edwards C; Nutt DJ; Wilson SJ Br J Psychiatry; 2002 Jun; 180():528-35. PubMed ID: 12042232 [TBL] [Abstract][Full Text] [Related]
8. The effects of paroxetine and nefazodone on sleep: a placebo controlled trial. Sharpley AL; Williamson DJ; Attenburrow ME; Pearson G; Sargent P; Cowen PJ Psychopharmacology (Berl); 1996 Jul; 126(1):50-4. PubMed ID: 8853216 [TBL] [Abstract][Full Text] [Related]
9. [A double-blind comparative study of the effectiveness and tolerance of paroxetine and amitriptyline in treatment of breast cancer patients with clinically assessed depression]. Möslinger-Gehmayr R; Zaninelli R; Contu A; Oberhoff C; Gutschow K; Schindler AE; Staab HJ Zentralbl Gynakol; 2000; 122(4):195-202. PubMed ID: 10795116 [TBL] [Abstract][Full Text] [Related]
10. Conventional and spectral power analysis of all-night sleep EEG after subchronic treatment with paroxetine in healthy male volunteers. Schlösser R; Röschke J; Rossbach W; Benkert O Eur Neuropsychopharmacol; 1998 Dec; 8(4):273-8. PubMed ID: 9928916 [TBL] [Abstract][Full Text] [Related]
11. Treatment of depression in patients with breast cancer: a comparison between paroxetine and amitriptyline. Pezzella G; Moslinger-Gehmayr R; Contu A Breast Cancer Res Treat; 2001 Nov; 70(1):1-10. PubMed ID: 11766999 [TBL] [Abstract][Full Text] [Related]
12. A controlled trial of antidepressants in patients with Parkinson disease and depression. Menza M; Dobkin RD; Marin H; Mark MH; Gara M; Buyske S; Bienfait K; Dicke A Neurology; 2009 Mar; 72(10):886-92. PubMed ID: 19092112 [TBL] [Abstract][Full Text] [Related]
13. Effect of chronic treatment with milnacipran on sleep architecture in rats compared with paroxetine and imipramine. Gervasoni D; Panconi E; Henninot V; Boissard R; Barbagli B; Fort P; Luppi PH Pharmacol Biochem Behav; 2002 Oct; 73(3):557-63. PubMed ID: 12151030 [TBL] [Abstract][Full Text] [Related]
14. Improved insulin sensitivity in 80 nondiabetic patients with MDD after clinical remission in a double-blind, randomized trial of amitriptyline and paroxetine. Weber-Hamann B; Gilles M; Lederbogen F; Heuser I; Deuschle M J Clin Psychiatry; 2006 Dec; 67(12):1856-61. PubMed ID: 17194262 [TBL] [Abstract][Full Text] [Related]
15. Analysis of sleep EEG microstructure in subchronic paroxetine treatment of healthy subjects. Röschke J; Kögel P; Schlösser R; Wagner P; Mann K; Rossbach W; Benkert O Psychopharmacology (Berl); 1997 Jul; 132(1):44-9. PubMed ID: 9272758 [TBL] [Abstract][Full Text] [Related]
16. Sleep laboratory studies on the single-dose effects of serotonin reuptake inhibitors paroxetine and fluoxetine on human sleep and awakening qualities. Saletu B; Frey R; Krupka M; Anderer P; Grünberger J; See WR Sleep; 1991 Oct; 14(5):439-47. PubMed ID: 1836894 [TBL] [Abstract][Full Text] [Related]
17. Comparison of tolerance of venlafaxine, paroxetine and amitriptyline in depression therapy. Miskovic M Med Arch; 2015 Apr; 69(2):107-9. PubMed ID: 26005260 [TBL] [Abstract][Full Text] [Related]
18. Pharmacological heterogeneity limits antidepressant study. Hale AS BMJ; 2003 Aug; 327(7409):289. PubMed ID: 12896954 [No Abstract] [Full Text] [Related]
19. How long should pindolol be associated with paroxetine to improve the antidepressant response? Zanardi R; Artigas F; Franchini L; Sforzini L; Gasperini M; Smeraldi E; Perez J J Clin Psychopharmacol; 1997 Dec; 17(6):446-50. PubMed ID: 9408806 [TBL] [Abstract][Full Text] [Related]
20. Double-blind, multicenter comparative study of sertraline and amitriptyline in hospitalized patients with major depression. Möller HJ; Gallinat J; Hegerl U; Arató M; Janka Z; Pflug B; Bauer H Pharmacopsychiatry; 1998 Sep; 31(5):170-7. PubMed ID: 9832348 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]